AMGEN TO PRESENT LONG-TERM OUTCOMES FOR LUMAKRAS® (SOTORASIB) IN KRAS G12C-MUTATED NSCLC AT AACR 2022

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

United Arab Emirates , Louisiana , United States , Qatar , Australia , Taiwan , Japan , Hong Kong , United Kingdom , Argentina , Brazil , Colombia , Canada , Mexico , Puerto Rico , New Orleans , Thailand , Israel , Kuwait , Singapore , Saudi Arabia , Switzerland , Turkey , Great Britain , American , Michael Strapazon , Megan Fox , Davidm Reese , Kyowa Kirin Co Ltd , Amgen , Plexium Inc , Drug Administration , Beigene Ltd , Exchange Commission , Biomedicines Inc , Clinical Research Excluding Trials , American Association For Cancer Research , Therapeutics Inc , Arrakis Therapeutics Inc , Amgen Inc , European Union Switzerland , Teneobio Inc , American Association , Cancer Research , Annual Meeting , Presentation Times , Late Breaking Oral Presentation , Clinical Trials Targeting , Oral Presentation , E Poster Virtual Presentation , Molecule Targeting Acute Myeloid Leukemia , E Poster In Person Presentation , Therapeutic Antibodies , Preclinical Characterization , Drug Targets , Drug Discovery , Through Project Orbis , Marketing Authorization Applications , Non Small Cell Lung Cancer , Lung Disease , Amgen Oncology , Dow Jones Industrial Average , Best Workplaces , Great Place , Generate Biomedicines , Arrakis Therapeutics , Five Prime Therapeutics , Thousand Oaks , Advancing Oncology , Coronavirus Pandemic , Technology , Science , Business , Health , Middle East , Ovarian Cancer , Pr Newswire , Cancer , Tumors , Lung Cancer ,